Twenty-Four-Hour Patterns in Occurrence and Pathophysiology of Acute Cardiovascular Events and Ischemic Heart Disease
- 24 September 2012
- journal article
- review article
- Published by Taylor & Francis Ltd in Chronobiology International
- Vol. 30 (1-2), 6-16
- https://doi.org/10.3109/07420528.2012.715843
Abstract
The scientific literature clearly establishes the occurrence of cardiovascular (CV) accidents and myocardial ischemic episodes is unevenly distributed during the 24 h. Such temporal patterns result from corresponding temporal variation in pathophysiologic mechanisms and cyclic environmental triggers that elicit the onset of clinical events. Moreover, both the pharmacokinetics and pharmacodynamics of many, though not all, CV medications have been shown to be influenced by the circadian time of their administration, even though further studies are necessary to better clarify the mechanisms of such influence on different drug classes, drug molecules, and pharmaceutical preparations. Twenty-four-hour rhythmic organization of CV functions is such that defense mechanisms against acute events are incapable of providing the same degree of protection during the day and night. Instead, temporal gates of excessive susceptibility exist, particularly in the morning and to a lesser extent evening (in diurnally active persons), to aggressive mechanisms through which overt clinical manifestations may be triggered. When peak levels of critical physiologic variables, such as blood pressure (BP), heart rate (HR), rate pressure product (systolic BP × HR, surrogate measure of myocardial oxygen demand), sympathetic activation, and plasma levels of endogenous vasoconstricting substances, are aligned together at the same circadian time, the risk of acute events becomes significantly elevated such that even relatively minor and usually harmless physical and mental stress and environmental phenomena can precipitate dramatic life-threatening clinical manifestations. Hence, the delivery of CV medications needs to be synchronized in time, i.e., circadian time, in proportion to need as determined by established temporal patterns in risk of CV events, and in a manner that averts or minimizes undesired side effectsKeywords
This publication has 99 references indexed in Scilit:
- Ventricular Tachyarrhythmias after Cardiac Arrest in Public versus at HomeNew England Journal of Medicine, 2011
- Time-of-day determines neuronal damage and mortality after cardiac arrestNeurobiology of Disease, 2009
- Acute myocardial infarction: Circadian, weekly, and seasonal patterns of occurrenceBiological Rhythm Research, 2007
- Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillationAmerican Heart Journal, 2003
- Plateletα2‐adrenoceptor alterations in patients with essential hypertensionBritish Journal of Clinical Pharmacology, 1999
- Double-peaking circadian variation in the occurrence of sustained supraventricular tachyarrhythmiasAmerican Heart Journal, 1990
- Ambulatory intra-arterial blood pressure in normal subjectsAmerican Heart Journal, 1990
- Concurrent Morning Increase in Platelet Aggregability and the Risk of Myocardial Infarction and Sudden Cardiac DeathNew England Journal of Medicine, 1987
- Circadian Variation in the Frequency of Onset of Acute Myocardial InfarctionNew England Journal of Medicine, 1985
- Sleep and blood pressure: further observationsAmerican Heart Journal, 1979